CML IV - Chronic phase chronic myeloid leukaemia/CML 2000
Completed
- Conditions
- eukaemiaCancerChronic myeloid leukaemia
- Registration Number
- ISRCTN61147621
- Lead Sponsor
- Medical Research Council (MRC) (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 800
Inclusion Criteria
1. The interval from diagnosis to registration does not exceed 3 months (if received only hydroxyurea in these 3 months proceed to register, if alpha Interferon (IFN) has been given contact co-ordinators)
2. They are aged 18-60; they have newly diagnosed CML
3. They have acceptable criteria for chronic phase
4. They have given informed consent and are willing to be randomised, there is no contraindication to collection of blood or marrow progenitor cells before treatment is commenced
5. They are not pregnant
Exclusion Criteria
Not provided at time of registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ength of survival, quality of life, cytogenetic response
- Secondary Outcome Measures
Name Time Method ot provided at time of registration